Business Context and Reporting Period
Company: Green Plains Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 22, 2025 (Event Date); August 27, 2025 (Signature Date)
Context: The Company entered into a definitive agreement to sell a specific ethanol production facility and concluded a strategic review process initiated in February 2024.
Key Financial Metrics and Transaction Details
- Transaction Value: Estimated sales price of $190 million in cash.
- Working Capital: Approximately $20 million included in the sales price, subject to adjustment at closing.
- Assets Sold: Ethanol plant in Rives, Tennessee (Green Plains Obion LLC) and related grain storage (8.2 million bushels).
- Capacity Impact: The facility represents 120 million gallons of nameplate capacity, or approximately 13% of the Company's reported ethanol production capacity.
- Buyer: POET Refining – Obion, LLC.
- Expected Closing: Third quarter of 2025.
Note: This filing does not provide consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company as a whole.
Material Changes and Strategic Developments
- Asset Divestiture: The sale of the Rives, Tennessee facility marks a significant reduction in the Company's ethanol production footprint (13% of capacity).
- Strategic Review Conclusion: The Board of Directors concluded a comprehensive strategic review that began in February 2024.
- Strategic Direction: The Board determined the Company is best positioned to deliver shareholder value by executing its current strategy under existing leadership, rather than pursuing alternative options explored during the review.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management views the transaction and the conclusion of the strategic review as providing a roadmap for continued operational execution and capital discipline.
- Closing Conditions: The transaction is subject to customary closing conditions, including the expiration of waiting periods under the Hart-Scott-Rodino (HSR) Act and the absence of governmental orders restraining the transaction.
- Termination Provisions: The agreement may be terminated by mutual consent, for breach, if closing does not occur by October 15, 2025, or if a Material Adverse Effect occurs.
- Risks: Forward-looking statements are subject to risks including the ability to consummate the transaction, obtain regulatory approvals, and potential termination of the agreement.
Investor Verification Checklist
- Verify the final closing date and whether the transaction closes within the projected third quarter of 2025.
- Confirm the final purchase price after working capital adjustments at closing.
- Monitor regulatory approvals, specifically the expiration of HSR Act waiting periods.
- Review subsequent filings for the impact of the 13% capacity reduction on future production guidance and earnings.
- Check for any updates regarding the strategic review process or changes in leadership contrary to the current announcement.